278 related articles for article (PubMed ID: 14715839)
1. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials.
Kunz D; Mahlberg R; Müller C; Tilmann A; Bes F
J Clin Endocrinol Metab; 2004 Jan; 89(1):128-34. PubMed ID: 14715839
[TBL] [Abstract][Full Text] [Related]
2. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Kunz D; Mahlberg R
J Sleep Res; 2010 Dec; 19(4):591-6. PubMed ID: 20561180
[TBL] [Abstract][Full Text] [Related]
3. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects.
Hack LM; Lockley SW; Arendt J; Skene DJ
J Biol Rhythms; 2003 Oct; 18(5):420-9. PubMed ID: 14582858
[TBL] [Abstract][Full Text] [Related]
4. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
Laakso ML; Lindblom N; Leinonen L; Kaski M
Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
[TBL] [Abstract][Full Text] [Related]
5. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
[TBL] [Abstract][Full Text] [Related]
6. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
7. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
8. Melatonin treatment for circadian rhythm sleep disorders.
Okawa M; Uchiyama M; Ozaki S; Shibui K; Kamei Y; Hayakawa T; Urata J
Psychiatry Clin Neurosci; 1998 Apr; 52(2):259-60. PubMed ID: 9628184
[TBL] [Abstract][Full Text] [Related]
9. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
[TBL] [Abstract][Full Text] [Related]
11. Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men.
Luboshitzky R; Levi M; Shen-Orr Z; Blumenfeld Z; Herer P; Lavie P
Hum Reprod; 2000 Jan; 15(1):60-5. PubMed ID: 10611189
[TBL] [Abstract][Full Text] [Related]
12. Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod.
Vandewalle G; Middleton B; Rajaratnam SM; Stone BM; Thorleifsdottir B; Arendt J; Dijk DJ
J Sleep Res; 2007 Jun; 16(2):148-55. PubMed ID: 17542944
[TBL] [Abstract][Full Text] [Related]
13. Hypnotic activity of melatonin.
Stone BM; Turner C; Mills SL; Nicholson AN
Sleep; 2000 Aug; 23(5):663-9. PubMed ID: 10947034
[TBL] [Abstract][Full Text] [Related]
14. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
Eckerberg B; Lowden A; Nagai R; Akerstedt T
Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women.
Kluge M; Gazea M; Schüssler P; Genzel L; Dresler M; Kleyer S; Uhr M; Yassouridis A; Steiger A
Psychoneuroendocrinology; 2010 Feb; 35(2):297-304. PubMed ID: 19647945
[TBL] [Abstract][Full Text] [Related]
16. The hypnotic effects of melatonin treatment on diurnal sleep in humans.
Matsumoto M
Psychiatry Clin Neurosci; 1999 Apr; 53(2):243-5. PubMed ID: 10459700
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome.
Rahman SA; Kayumov L; Shapiro CM
Sleep Med; 2010 Feb; 11(2):131-6. PubMed ID: 20044310
[TBL] [Abstract][Full Text] [Related]
18. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
19. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.
Kayumov L; Brown G; Jindal R; Buttoo K; Shapiro CM
Psychosom Med; 2001; 63(1):40-8. PubMed ID: 11211063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
